Literature DB >> 19434728

Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis.

Ulf Titze1, Gritta Janka, E Marion Schneider, Friedrich Prall, Dieter Haffner, Carl Friedrich Classen.   

Abstract

Both hemophagocytic lymphohistiocytosis (HLH) and Kawasaki disease (KD) are diagnosed in patients with prolonged resistant fever by using a scoring system. Concurrent manifestation of both conditions has been reported previously. We describe an infant of 7 weeks whose condition fulfilled the criteria of HLH, but who, after clinical response to treatment, suddenly died from a myocardial infarction at 11 weeks. Post-mortem examination revealed a previously unknown coronary arteritis typical for KD. Since it is difficult to distinguish between KD and HLH, both diseases should be considered in young children with overlapping symptoms. Repeated echocardiograms may be helpful in these cases. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19434728     DOI: 10.1002/pbc.22098

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

1.  Forme Fruste of HLH (haemophagocytic lymphohistiocytosis): diagnostic and therapeutic challenges.

Authors:  Susumu Inoue; Chetna Mangat; Yaseen Rafe'e; Mahesh Sharman
Journal:  BMJ Case Rep       Date:  2015-01-29

2.  Hemophagocytosis in the Acute Phase of Fatal Kawasaki Disease in a 4 Month-Old Girl.

Authors:  Vehbi Doğan; Erhan Karaaslan; Samet Özer; Rüveyda Gümüşer; Resul Yılmaz
Journal:  Balkan Med J       Date:  2016-07-01       Impact factor: 2.021

3.  Very high serum ferritin levels in three newborns with Kawasaki-like illness.

Authors:  Arwa Nasir; Hosam Al Tatari; Mohamed A Hamdan
Journal:  Paediatr Child Health       Date:  2012-04       Impact factor: 2.253

4.  Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease.

Authors:  Hae-Ryong Kang; Yong-Hoon Kwon; Eun-Sun Yoo; Kyung-Ha Ryu; Ji Yoon Kim; Heung-Sik Kim; Hwang Min Kim; Young-Ho Lee
Journal:  Blood Res       Date:  2013-12-24

Review 5.  Epidemiology and management of Kawasaki disease.

Authors:  Nadia J C Luca; Rae S M Yeung
Journal:  Drugs       Date:  2012-05-28       Impact factor: 11.431

6.  A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.

Authors:  Yoshiki Kawamura; Hiroki Miura; Yuji Matsumoto; Hidetoshi Uchida; Kazuko Kudo; Tadayoshi Hata; Yoshinori Ito; Hiroshi Kimura; Tetsushi Yoshikawa
Journal:  BMC Pediatr       Date:  2016-10-28       Impact factor: 2.125

7.  Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide.

Authors:  Jung Eun Choi; Yujin Kwak; Jung Won Huh; Eun-Sun Yoo; Kyung-Ha Ryu; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2018-05-28

8.  Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.

Authors:  Jinghong Chen; Xuehua Wang; Ping He; Yazhen Li; Mengya Si; Zhichen Fan; Xiaolan Chang; Qindong Xie; Xiaoyang Jiao
Journal:  J Med Virol       Date:  2015-10-19       Impact factor: 2.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.